Skip to content
400400400TMCTMCTMC

Drawing based on the label description. No photo yet.

“PREZISTA (darunavir) 400 mg tablets are supplied as light orange, oval-shaped, film-coated tablets containing darunavir ethanolate equivalent to 400 mg of darunavir per tablet. Each tablet is debossed with "400" on one side and "TMC" on the other side”

400 TMC pill

Pill with imprint 400 TMC is orange, oval, 19 mm and has been identified as Darunavir Ethanolate 400 mg. It is used for HIV. It is supplied by State of Florida Doh Central Pharmacy.

Darunavir Ethanolate 400 mg

Imprint
400 TMC
Strength
400 mg
Used for
HIV
Color
Orange
Shape
Oval
Size
19 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
State of Florida Doh Central Pharmacy
Drug class
Antiviral (protease inhibitor)
NDC
53808-0672, 59676-561, 53808-0672-1

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Darunavir Ethanolate pills and guides

What is Darunavir Ethanolate used for?

Darunavir Ethanolate is used for HIV.

Medicine type
Antiviral (protease inhibitor)
Official uses from the US prescribing label

Adult Patients

PREZISTA®, co-administered with ritonavir (PREZISTA/ritonavir), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV-1) infection.

This indication is based on analyses of plasma HIV RNA levels and CD4+ cell counts from 2 controlled Phase 3 trials of 48 weeks duration in antiretroviral treatment-naïve and treatment-experienced patients and 2 controlled Phase 2 trials of 96 weeks duration in clinically advanced, treatment-experienced adult patients.

Pediatric Patients

PREZISTA, co-administered with ritonavir (PREZISTA/ritonavir), and with other antiretroviral agents, is indicated for the treatment of HIV infection in pediatric patients 6 years of age and older.

This indication is based on 24-week analyses of plasma HIV RNA levels and CD4+ cell counts from an open-label Phase 2 trial in antiretroviral treatment-experienced pediatric patients 6 to < 18 years of age.

In treatment-experienced adult and pediatric patients, the following points should be considered when initiating therapy with PREZISTA/ritonavir:

  • Treatment history and, when available, genotypic or phenotypic testing should guide the use of PREZISTA/ritonavir.
  • The use of other active agents with PREZISTA/ritonavir is associated with a greater likelihood of treatment response.

From the FDA-approved label on DailyMed (published Aug 24, 2010).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 400 and the other side shows TMC.
  • It is orange, oval, 19 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Prezista.

Ingredients

Active: Darunavir Ethanolate

Inactive: Silicon Dioxide, Crospovidone, Magnesium Stearate, Cellulose, Microcrystalline, Fd&c Yellow No. 6, Polyethylene Glycol 3350, Polyvinyl Alcohol, Talc, Titanium Dioxide

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Darunavir Ethanolate pills